Is venetoclax a targeted drug or a chemotherapy drug?

Venetoclax is a targeted drug, not a chemotherapy drug. Veneclat is a drug used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML) drugs, the trade names are Venclexta and Venclyxto.

The most common side effects of venetoclax are low neutrophil levels, diarrhea, nausea, anemia (low red blood cell count), nose and throat infections, and fatigue. Venecla attaches to a protein called Bcl-2. This protein is found in high concentrations in CLL cancer cells, helping them survive longer in the body and making them resistant to anti-cancer drugs. By attaching toBcl-2 and blocking its action, venectin causes cancer cells to die, thereby slowing the progression of the disease.

Drinking plenty of water every day can help prevent an adverse reaction called tumor lysis syndrome. Your doctor may also prescribe medications to lower uric acid in the blood (such as allopurinol). Do not eat or drink grapefruit products, star fruits, or Seville oranges while using this medicine. Half of the patients who received venetoclax + azacitidine were still alive at 15 months, while those who received azacitidine alone were still alive at 10 months. Venekra may not work for everyone. Venetoclax can cause serious side effects, including tumor lysis syndrome, low white blood cell counts, and infections. The retail price of generic venetoclax100mg120 tablets ranges from 2 to 6 more than a thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.